Clinical trials
Completed Phase 3 Rheumatic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Regeneron Pharmaceuticals | 4 |
| Novartis Pharmaceuticals | 2 |
| Organogenesis | 2 |
| Amgen | 1 |
| Biocad | 1 |
| Janssen Research & Development, LLC | 1 |
| Mabion SA | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| Pfizer | 1 |
| Tonix Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rheumatic Diseases | 16 |
| Arthritis | 9 |
| Joint Diseases | 9 |
| Musculoskeletal Diseases | 7 |
| Arthritis, Rheumatoid | 6 |
| Gout | 6 |
| Genetic Diseases, Inborn | 4 |
| Metabolic Diseases | 4 |
| Metabolism, Inborn Errors | 4 |
| Purine-Pyrimidine Metabolism, Inborn Errors | 4 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.